With the analysis among 467 patents, we discovered top 46 key players by total patent application. Theravance Biopharma R&D IP LLC, Novartis AG, Bioprojet SCR are dominant in this area. They take 67.02% of the total patent filing.
Theravance Biopharma R&D IP LLC
California, United States
Patent: 231
Basel-Stadt, Switzerland
Patent: 41
Merrell Dow Pharmaceuticals, Inc.
California, United States
Patent: 19
New Jersey, United States
Patent: 13
Telangana, India
Patent: 6
The Board of Regents of The University of Texas System
Texas, United States
Patent: 4
With the analysis among 2 patents, we discovered top 2 start-ups by total patent application.
New Jersey, United States
Patent: 1
Texas, United States
Patent: 1
With the analysis among related 27 patents applied in the last 5 years. We discover 8 most active companies in this area. The fast-growing Theravance Biopharma R&D IP LLC, Ache Laboratorios Farmaceuticos S.A., Hetero Labs Ltd. take 66.67% of patent filing during this period.
Theravance Biopharma R&D IP LLC
California, United States
Patent: 14
Ache Laboratorios Farmaceuticos S.A.
São Paulo, Brazil
Patent: 2
Telangana, India
Patent: 2
Guangzhou Baiyunshan Tianxin Pharmaceutical Co. Ltd.
Guangdong Sheng, China
Patent: 1
Shandong Sheng, China
Patent: 1
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 1
With the analysis among related 27 patents in last 5 years, we discover 4 new entrants. Ache Laboratorios Farmaceuticos S.A., Hytest Oy, Guangzhou Baiyunshan Tianxin Pharmaceutical Co. Ltd. are the most active new entrants in this area.
Ache Laboratorios Farmaceuticos S.A.
São Paulo, Brazil
Patent: 2
Guangzhou Baiyunshan Tianxin Pharmaceutical Co. Ltd.
Guangdong Sheng, China
Patent: 1
Shandong Sheng, China
Patent: 1
With the analysis among 11 patents, we discovered top 2 universities and scientific research institutions by total patent application.
University of Texas at El Paso
Texas, United States
Patent: 1
Shandong Sheng, China
Patent: 1